Source: Annual Congress 2001 - Therapy for non-small cell lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
V. Pechman, J. Zahlava (Plzen, Czech Republic). Value of Tc-99m-MIBI scintigraphy in predicting the cytostatic responsiveness of the non-small lung cancer. Eur Respir J 2001; 16: Suppl. 31, 2582

Member's Comments

No comment yet.

Related content which might interest you: Significance of Tl-201 and MIBI-99mTc lung scintigraphy in advanced lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 247s Year: 2003 Prognostic value of integrated FDG-PET/CT in non-small cell lung cancer Source: Annual Congress 2008 - New imaging techniques in chest imaging Year: 2008 PET scanning poorly predicts response to pre-operative chemotherapy in non-small cell lung cancer Source: ISSN=ISSN 1810-6838, ISBN=, page=54 Year: 2004 Comparision of FDG PET/CT and bone scanning for bone metastases in operable non-small cell lung cancer Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009 Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 Accuracy of remediastinoscopy in restaging of lung cancer Source: Breathe 2008; 5: 66 Year: 2008 Extra-mediastinal FDG-PET hot-spots in a study of mediastinal staging of non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 458s Year: 2004 The value of lung perfusion scintigraphy in the prediction of postoperative function in lung cancer Source: Annual Congress 2004 - Assessment of lung function before resection of lung cancer Year: 2004 Endobronchial ultrasound for mediastinal restaging in non-small cell lung cancer Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019 Integrated FDG-PET/CT for improved T and N staging of non-small-cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 784s Year: 2006 Features of N-staging in left-sided non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 719s Year: 2006 FDG-PET SUVmax is an independent prognostic indicator in patients with non-small cell lung cancer Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011 PET/CT of lung cancer Source: International Congress 2018 – PG4 Imaging of the chest Year: 2018 Scintigraphy with 99mTc-depreotide has a high sensitivity in detecting lung cancer Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques Year: 2007 Staging of non-small-cell lung cancer with FDG-PET/CT: Is there a correlation of morphologic tumor characteristics and metabolic activity? Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life Year: 2012 Correlatin between PET scan and cytokine in non-small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 N-staging in CT N0-N1 non-small cell lung cancer patients: is there any place for mediastinoscopy? Source: Annual Congress 2007 - Staging, diagnostic procedures and complex situations in thoracic surgery Year: 2007 Possibility of the specific efficacy of gefitinib for miliary lung metastasis in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 303s Year: 2004 Role of Tc-99m MIBI chest SPECT to detect mediastinal lymph node metastasis in patients with non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 314s Year: 2005 Contribution of tumor markers to pretreatment staging of operable lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 360s Year: 2003